EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the clinical outcomes and molecular characteristics of Acinetobacter baumannii bloodstream infections: a study of sequence types, capsular types, and drug resistance in China

Jiao Chen, Yanting Shao, Zhibin Cheng, Guanghui Li, Fen Wan, Chenyan Gao, Danqin Wu, Dandan Wei, Yang Liu, Rong Li

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1549940 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Jiao Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Laboratory Medicine, Nanchang Medical College, Nanchang, China. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Acinetobacter Infections, Bacteremia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bloodstream infections (BSIs) caused by Acinetobacter baumannii have been associated with high mortality. To improve the outcomes of patients, this study explored the clinical characteristics and outcomes of patients with BSIs, as well as the phenotypic and genomic characteristics of these isolates.

Methods

A retrospective cohort study was conducted involving A. baumannii BSIs cases from 2020 to 2023 in a tertiary hospital. The clinical characteristics of all A. baumannii isolates were evaluated. Virulence phenotypes of all isolates were evaluated using the growth curve, biofilm-forming assay, antiserum complement killing, and G.mellonella killing assay. Furthermore, whole-genome sequencing (WGS) was utilized to analyze genomic characteristics.

Results

The 30-day mortality rate of 67 patients with BSIs was 55.22%. Patients in the death group had significantly lower platelet counts and higher CRP levels than those in the survival group. Additionally, higher rates of antibiotic use (≥2 classes) and greater carbapenem exposure were observed. Among the isolates, CRAb accounted for 80.6%, ST2 accounted for 76.12%, and KL2/3/7/77/160 accounted for 65.67%. The predominant KL type was KL3, found in 19.4% of the isolates. All ST2 and KL2/3/7/77/160 isolates were CRAb. Among the isolates, 90.7% of the CRAb isolates coharbored bla OXA-23 and bla OXA-66 , while one coharbored blaNDM-1 and bla OXA-23 . Compared with non-ST2 and non KL2/3/7/ 77/160 infections, ST2 and KL2/3/7/77/160 infections had higher mortality rates (66.0% vs. 23.5%, P=0.002; 65.90% vs. 34.78%, P=0.015). Patients with ST2 and KL2/3/7/77/160 infections underwent more invasive procedures, received two or more antibiotics and carbapenem therapy before isolation, and had lower serum albumin levels. These isolates exhibited significantly higher resistance to antimicrobial agents. No significant differences in virulence phenotypes were observed between the two groups, except for biofilm formation between the ST2 and non-ST2 groups (P=0.035). However, these isolates harbored more virulence genes related to iron uptake and biofilm formation.

Conclusion

The mortality rate associated with BSIs caused by A. baumannii is high. It is of great significance for clinicians to pay attention to the risk factors of the clinical characteristics of patients and to identify the ST and KL types of the strains causing the infection at an early stage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAcinetobacter InfectionsBacteremiaHumansChinaRetrospective StudiesMaleFemaleMiddle AgedAnti-Bacterial AgentsAgedWhole Genome SequencingBiofilmsMicrobial Sensitivity TestsDrug Resistance, Multiple, BacterialAdultAged, 80 and overVirulenceVirulence FactorsBacterial CapsulesTertiary Care CentersGenome, Bacterial

Stichwörter der Autor:innen

Acinetobacter baumanniibloodstream infectioncapsular typecarbapenem-resistant Acinetobacter baumanniisequence type

Substanzen

Anti-Bacterial AgentsVirulence Factors

Autor:innen und Institutionen

  • School of Laboratory Medicine, Nanchang Medical College, Nanchang, China.
  • School of Information Engineering, East China Jiaotong University, Nanchang, China.
  • Neurology Intensive Care Unit (ICU), First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Department of Clinical Microbiology, the First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Clinical Laboratory, China-Japan Friendship Jiang Xi Hospital, Nanchang, China.
  • Department of Clinical Laboratory & Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial People's Hospital & The first Affiliated Hospital of Nanchang Medical College, Nanchang, China.

Zitieren

APA

Chen, J., Shao, Y., Cheng, Z., Li, G., Wan, F., Gao, C., Wu, D., Wei, D., Liu, Y., & Li, R. (2025). Exploring the clinical outcomes and molecular characteristics of Acinetobacter baumannii bloodstream infections: a study of sequence types, capsular types, and drug resistance in China. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1549940

Vancouver

Chen J, Shao Y, Cheng Z, Li G, Wan F, Gao C, et al. Exploring the clinical outcomes and molecular characteristics of Acinetobacter baumannii bloodstream infections: a study of sequence types, capsular types, and drug resistance in China. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1549940

BibTeX
@article{Chen2025,
  author = {Chen, Jiao and Shao, Yanting and Cheng, Zhibin and Li, Guanghui and Wan, Fen and Gao, Chenyan and Wu, Danqin and Wei, Dandan and Liu, Yang and Li, Rong},
  title = {Exploring the clinical outcomes and molecular characteristics of Acinetobacter baumannii bloodstream infections: a study of sequence types, capsular types, and drug resistance in China},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1549940}
}
Kostenlos starten →